SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-002741
Accepted
2024-09-09 00:15:09
Documents
1
Effectiveness Date
2024-09-06
Registration Form
F-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-24-002741.txt   1935
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-281750 | Film No.: 241285698
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)